Ultomiris
Active substance: ravulizumab
SOLUTION, CONCENTRATE · RAVULIZUMAB 1100 mg/11mL
United StatesActive
Marketing holder: Alexion Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- RAVULIZUMAB · 1100 mg/11mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12091-7627-7863-96e6-d1591112c0ed,01a12091-7629-74e8-9ae1-fc8d78490cf4,01a12091-762b-71e8-9c7f-6503eb3f4429;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 25682-028
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 25682-028 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 25682-028 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 25682-028 · Verified 2026-10-09 · open in source